*Di Stafford* from *The Patient Practice* comments on PwC's recent report: *Pharma 2020 - The Vision* and highlights the renewed focus on patients as key influencing stakeholders, and the role patient understanding can play in value creation.
Di Stafford from The Patient Practice comments on PwC's recent report: Pharma 2020 - The Vision and highlights the renewed focus on patients as key influencing stakeholders, and the role patient understanding can play in value creation.
Ive just been reading Price Waterhouse Coopers recent report:
Phil Taylor reports on the commercial and scientific opportunities facing medical scientific liaisons (MSLs)
Andrew Tolve investigates the opportunities and challenges for pharma’s use of cloud computing
Phil Taylor explores how pharma’s relationship to key opinion leaders is changing - for the better
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs